Source: Annual Congress 2013 –Modern approach to various clinical settings



Rating:

Share or cite this content

Citations should be made in the following way:
M. Duna, A. Croitoru, D. Jipa, I. Nicolescu Veselu, C. Toma, S. Dumitrache-Rujinski, I. Belaconi, C. Tudose, M. Bogdan (Bucharest, Romania). Eosinophilic pneumoniae. Series of clinical cases. Eur Respir J 2013; 42: Suppl. 57, 2182

Member's Comments

No comment yet.

Related content which might interest you: Modern etiology of severe community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Microbial aetiology and outcomes of CAP in bronchiectatic patients Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Asthma diagnosis in children with community-acquired pneumonia: New challenges Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Clinical characteristics of 11 cases of pulmonary abscess in children Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Atorvastatin as novel treatment in bronchiectasis patients colonized with pseudomonas aeruginosa Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Etiology and evolution of bronchiectasis in men Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia Source: International Congress 2014 – ILDs 4 Year: 2014 Clinical presentation of Legionnaires’ disease during an outbreak: The typical presentation of an atypical pathogen Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Surfactant-enforced treatment of pseudomonas-induced pneumonia Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Necrosis as a predictor of infection in granulomatous lung disease Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Year: 2014 Community acquired pneumonia in asthma patients Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Clnico-microbiological analysis of mycobacaterium abscessus complex in Japan Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013